Search Results
Jul 16, 2026, 07:00 ET Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development, Upcoming Webinar Hosted by Xtalks
understanding of how quantitative neuroimmune biomarker measurements can support neuroimmunology research and therapeutic development.Join Sannette Hall, PhD, Senior Field Applications Scientist,
More news about: Xtalks
Jul 16, 2026, 06:45 ET Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
[email protected]; (Investors)Jason Awe, PhD; [email protected] (Investors)
More news about: Eli Lilly and Company
Jul 16, 2026, 06:15 ET Schlumberger Foundation Honors Nine Women Scientists and Engineers with the 2026 Faculty for the Future Impact Prize
education.Established in 2004, Faculty for the Future supports women scientists and engineers from emerging and developing economies in pursuing PhD and postdoctoral STEM research at leading institutions worldwide. In 2026, the program reached the milestone of funding 1,000 Fellows globally.For
More news about: Schlumberger Foundation
Jul 16, 2026, 04:00 ET Slone Partners Places Amer Mirza, PhD, as Chief Scientific Officer at Prolynx
Amer Mirza, PhD, as Chief Scientific Officer (CSO) at
More news about: Slone Partners
Jul 15, 2026, 18:30 ET Copyright Cases Dominate as Regulatory and Product Liability Challenges Emerge in the Q2 2026 J.S. Held AI Disputes Monitor
Blake Pellman, PhD, Senior User Experience Researcher at J.S. Held. "Like any other kind of product, one needs to understand whether the system was being used for its intended
More news about: J.S. Held
Jul 15, 2026, 17:47 ET /C O R R E C T I O N -- Cincinnati Children's Hospital Medical Center/
Nadine Kasparian, PhD, PMH-C, who founded the Heart and Mind Wellbeing Center at Cincinnati Children's in 2023.The breastfeeding intervention will be led by William
More news about: Cincinnati Children's Hospital Medical Center
Jul 15, 2026, 13:49 ET The Inner Circle acknowledges Janet L. Polach, Ph.D as an Inner Circle Five Year
multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-janet-l-polach-phd-as-an-inner-circle-five-year-302826606.htmlSOURCE
More news about: The Inner Circle
Jul 15, 2026, 13:49 ET The Inner Circle acknowledges Dr. Tyrone Clark as a Pinnacle Professional of The Year
challenges and opportunities.His academic journey reflects his dedication to theological scholarship and spiritual leadership. Dr. Clark earned a PhD in Theology from Ascend Christian University in 2025, following a Master's degree in Theology from The Theological Institute of Florida in 2022. He previously
More news about: The Inner Circle
Jul 15, 2026, 11:55 ET BIOTRONIK Neuro Acquires Spinal Cord Stimulation System from Soin Neuroscience
our own. This agreement lets that work continue inside an organization built to bring it to patients at scale. I am also grateful to Dr Eric Schepis, PhD whose brilliance, conceptual designs, and co-inventorship on a portion of our patents helped pave the way."BIOTRONIK is a diversified, family-owned
More news about: Soin Neuroscience
Jul 15, 2026, 11:46 ET BIOTRONIK Neuro Acquires Spinal Cord Stimulation System from Soin Neuroscience
our own. This agreement lets that work continue inside an organization built to bring it to patients at scale. I am also grateful to Dr Eric Schepis, PhD whose brilliance, conceptual designs, and co-inventorship on a portion of our patents helped pave the way."BIOTRONIK is a diversified, family-owned
More news about: Soin Neuroscience
Jul 15, 2026, 11:01 ET The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.
and remain in place. That is a requirement problem, not a marketing problem, and it is why the category remains open," said Claudia Chavez-Munoz, MD, PhD, Chief Scientific Officer. "We are evaluating CXU™ against that requirement through disciplined preclinical work."The Bigger Lesson: Demand
More news about: Equity Insider
Jul 15, 2026, 09:54 ET Cumulus Neuroscience présente, lors du congrès annuel de l'AAIC 2026, des données montrant qu'une tâche numérique de deux minutes atteint ou dépasse les critères de référence cliniques en matière de pré-sélection des participants à un essai clinique sur la maladie d'Alzheimer.
la pathologie d'Alzheimer même chez des participants à l'étude qui semblent cognitivement normaux lors des tests standard », a déclaré Brian Murphy, PhD, cofondateur et directeur scientifique de Cumulus. « Ces données confirment que le Symbol Swap pourrait constituer un filtre de première ligne très efficace,
More news about: Cumulus Neuroscience
Jul 15, 2026, 09:17 ET KU Medical Center Academic Leader Named Provost at Kansas City University
2026 /PRNewswire/ -- Kansas City University (KCU) and the University of Kansas Medical Center announce the appointment of Abiodun E. Akinwuntan, PhD, MBA, MPH, MIH, as provost and executive vice president for Academic, Research and Clinical Affairs at KCU.
More news about: Kansas City University
Jul 15, 2026, 09:04 ET New Peer-Reviewed Study Published in Dermatology and Therapy Adds to Clinical Evidence Showing Nutrafol Hair Growth Nutraceuticals Improve Hair Growth in Women
self-assessment questionnaires throughout the study.The research was authored by Rubaina Dang ND, Raja K. Sivamani MD MS AP, Adina Hazan PhD, Isabelle Raymond PhD, and newly published in Dermatology and Therapy. The findings were initially presented as an abstract at the 2026 World Congress for
More news about: NUTRAFOL
Jul 15, 2026, 09:00 ET Vytalogy Wellness Bolsters Scientific Advisory Board with Six New Members
of MedicineHelen Burgess, PhD – Professor of Psychiatry and Co-Director of the Sleep and Circadian Research Laboratory, University of MichiganChris Winter, MD – Sleep researcher, neurologist and authorJames Brooks, PhD – Adjunct Professor of Food, Nutrition
More news about: Vytalogy Wellness
Jul 15, 2026, 09:00 ET Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board
multimedia:https://www.prnewswire.com/news-releases/bambusa-therapeutics-appoints-howard-liang-phd-to-its-board-of-directors-and-establishes-scientific-advisory-board-302825989.htmlSOURCE
More news about: Bambusa Therapeutics
Jul 15, 2026, 08:45 ET CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development
multimodal AI and precision diagnostics capabilities within clinical development programs.Media ContactsStéphanie Bussières-Marmen, PhDDirector, Global [email protected]
More news about: CellCarta
Jul 15, 2026, 08:07 ET Copyright Cases Dominate as Regulatory and Product Liability Challenges Emerge in the Q2 2026 J.S. Held AI Disputes Monitor
Blake Pellman, PhD, Senior User Experience Researcher at J.S. Held. "Like any other kind of product, one needs to understand whether the system was being used for its intended
More news about: J.S. Held
Jul 15, 2026, 08:00 ET CENTURY LITHIUM REPORTS LITHIUM METAL FROM ANGEL ISLAND DEMONSTRATED IN BATTERY CELLS UNDER U.S. ARMY SBIR PROGRAM
centurylithium.com.ON BEHALF OF CENTURY LITHIUM CORP.WILLIAM WILLOUGHBY, PhD., PE President & Chief Executive Officer
More news about: Century Lithium Corp.
Jul 15, 2026, 07:45 ET Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study)
through its anti-cancer mechanisms of action that cause tumor cell necrosis and ignite an anti-cancer immune-based response," said Markus Joerger, MD-PhD from the Department of Medical Oncology and Hematology at Health Ostschweiz, Professor of Medicine at the University of Basel, Co-Chair of the SCI's
More news about: Intensity Therapeutics Inc.
Jul 15, 2026, 06:00 ET Creyos Cognitive Assessments Featured in Two Studies at AAIC 2026
setting."Highlights from AAIC 2026 presentations:1. Advancing Earlier Detection of Cognitive Impairment Western University — Adrian Owen, PhD, OBE, FRS, FRSC, FCAHSThe Creyos Dementia Protocol (CDP) is a longitudinal study extending
More news about: Creyos
Jul 15, 2026, 06:00 ET HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026
aging-related diseases. We are proud that this science is being presented at one of the world's leading metabolic disease congresses." — J. Robert Coleman, PhD, MBA, Chief Executive Officer, HERVolution TherapeuticsAbout HERVolution TherapeuticsHERVolution
More news about: HERVolution Therapeutics
Jul 15, 2026, 05:11 ET Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer's Trial Pre-enrichment
administer— and that it picks up Alzheimer's pathology even in study participants who look cognitively normal on standard tests," said Brian Murphy, PhD, Cumulus Co-Founder and CSO. "This data confirms that Symbol Swap may be a powerful first-line filter, preceding plasma biomarkers or feeding a multimodal
More news about: Cumulus Neuroscience
Jul 15, 2026, 05:00 ET Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer's Trial Pre-enrichment
administer— and that it picks up Alzheimer's pathology even in study participants who look cognitively normal on standard tests," said Brian Murphy, PhD, Cumulus Co-Founder and CSO. "This data confirms that Symbol Swap may be a powerful first-line filter, preceding plasma biomarkers or feeding a multimodal
More news about: Cumulus Neuroscience
Jul 15, 2026, 04:00 ET Market performance in H2 2026 will be driven by AI, despite geopolitical uncertainty and persistent inflation: Natixis Investment Managers Strategists Survey 2026
Harris | OakmarkBrian Horrigan, PhD, CFA®Chief Economist
More news about: Natixis Investment Managers